Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1

Status

Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 4Breast 3Other hematologic neoplasm 2Gynecologic 2Endocrine 2Sarcoma 1NET 1Lymphoid 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1Toxemia 1Primary Ovarian Insufficiency 1Polycystic Ovary Syndrome 1Diabetes, Gestational 1Cardiovascular Diseases 1

Interventions

Fulvestrant 83Letrozole 77Paclitaxel 76pembrolizumab 72Specimen Handling 66Trastuzumab 62Carboplatin 57Magnetic Resonance Spectroscopy 51ribociclib 49Capecitabine 48Anastrozole 47pertuzumab 46palbociclib 43exemestane 40abemaciclib 40Cyclophosphamide 40Tamoxifen 39Biopsy 38Docetaxel 30trastuzumab deruxtecan 29Taxes 28Radiotherapy 28Gemcitabine 25Blood Specimen Collection 25130-nm albumin-bound paclitaxel 25olaparib 22Surveys and Questionnaires 22Standard of Care 22sacituzumab govitecan 20eribulin 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Positron-Emission Tomography × Breast × 90 days × Clear all
NCT05632601 2026-05-08

HER-CROWN

Ottawa Heart Institute Research Corporation

Phase NA Active not recruiting
176 enrolled
BreastGynecologic

Breast Neoplasms, Cardiovascular Diseases, Polycystic Ovary Syndrome, Toxemia, Diabetes, Gestational, Primary Ovarian Insufficiency

NCT06586047 2026-03-27

Breast Cancer PSMA PET

University of Iowa

Phase EARLY_PHASE1 Recruiting
30 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00367666 2026-03-10

Using Diagnostic Tools to Stage Breast Cancer

University of Pennsylvania

Phase NA Active not recruiting
400 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡